Jane Street Group, LLC Verve Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 216,901 shares of VERV stock, worth $986,899. This represents 0.0% of its overall portfolio holdings.

Number of Shares

216,901

Previous 253,800 14.54%

Holding current value

$986,899

Previous $1.24 Million 15.27%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.4 - $7.86 $162,355 - $290,026	-36,899 Reduced 14.54%	216,901 $1.05 Million
Q2 2024 Aug 14, 2024	BUY	$4.76 - $12.79 $1.08 Million - $2.9 Million	226,657 Added 835.05%	253,800 $1.24 Million
Q1 2024 May 15, 2024	SELL	$10.81 - $17.96 $2.65 Million - $4.4 Million	-245,083 Reduced 90.03%	27,143 $360,000
Q4 2023 Feb 14, 2024	BUY	$8.84 - $18.7 $2.23 Million - $4.72 Million	252,441 Added 1275.92%	272,226 $3.79 Million
Q3 2023 Nov 14, 2023	SELL	$11.42 - $20.82 $743,887 - $1.36 Million	-65,139 Reduced 76.7%	19,785 $262,000
Q2 2023 Aug 14, 2023	SELL	$13.34 - $19.9 $929,344 - $1.39 Million	-69,666 Reduced 45.07%	84,924 $1.59 Million
Q1 2023 May 15, 2023	BUY	$14.3 - $24.01 $2.01 Million - $3.38 Million	140,774 Added 1018.92%	154,590 $2.23 Million
Q4 2022 Feb 14, 2023	BUY	$17.85 - $40.7 $246,615 - $562,311	13,816 New	13,816 $267,000
Q2 2022 Aug 16, 2022	SELL	$11.14 - $23.17 $137,389 - $285,755	-12,333 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$20.92 - $39.36 $749,019 - $1.41 Million	-35,804 Reduced 74.38%	12,333 $281,000
Q4 2021 Feb 15, 2022	BUY	$31.94 - $54.82 $1.54 Million - $2.64 Million	48,137 New	48,137 $1.78 Million
Q3 2021 Nov 16, 2021	SELL	$46.0 - $73.99 $436,632 - $702,313	-9,492 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$31.92 - $60.25 $302,984 - $571,893	9,492 New	9,492 $572,000

Others Institutions Holding VERV

# of Institutions

186

Shares Held

73.3M

Call Options Held

85K

Put Options Held

215K

View Full List

About Verve Therapeutics, Inc.

Ticker VERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,942,300
Market Cap $273M
Description
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...

More about VERV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Verve Therapeutics, Inc. Transaction History